Evolva Announces Interim Results of Veri-te™ Resveratrol Study, SupplySide West 2019 report

October 29th, 2019
|

By: Sebastian Krawiec

October 29, 2019

Evolva announced the interim results of a two-year clinical trial that evaluated the effects of resveratrol in post-menopausal women. The study, called Resveratrol Supporting Healthy Aging in Women (RESHAW), was conducted by the University of Newcastle in Australia and funded by the country’s National Health and Medical Research Council. The largest and longest-running trial of its kind, RESHAW investigated the impact of Evolva’s branded Veri-te™ resveratrol on cognitive performance as well as a number of secondary outcomes such as overall quality of life, bone health, and blood glucose. Continue Reading